Sarepta Therapeutics Inc at UBS BioPharma Conference Transcript
Well, good morning, and welcome to day 2 of the UBS Biopharma Conference. I'm Colin Bristow, one of the biotech analysts. It's my pleasure to have Sarepta Therapeutics here with us today. On behalf of the company, we have CFO, Ian Estepan, Ian, thank you for spending the time with us.
Thank you so much for having us. And obviously, I'm going to be making some forward-looking statements. So obviously, you should refer to our SEC documents for the appropriate warnings around that.
Questions & Answers
So a busy couple of weeks for you guys. Maybe we could start with just walk us through the chain of events from the unblinding of EMBARK to kind of where we are today.
Yes. So obviously
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
